CLOVIS ONCOLOGY INC's ticker is and the CUSIP is 189464AB6. A total of 36 filers reported holding CLOVIS ONCOLOGY INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $22,019,000 | -13.1% | 24,758,000 | -9.3% | 0.43% | -23.8% |
Q1 2019 | $25,344,000 | +62.6% | 27,289,000 | +47.4% | 0.56% | +48.3% |
Q4 2018 | $15,585,000 | -35.5% | 18,512,000 | -28.3% | 0.38% | -24.3% |
Q3 2018 | $24,147,000 | +145.7% | 25,827,000 | +182.9% | 0.50% | +140.6% |
Q2 2018 | $9,826,000 | -9.2% | 9,129,000 | -1.6% | 0.21% | -2.8% |
Q1 2018 | $10,824,000 | +9.3% | 9,279,000 | +26.6% | 0.21% | +12.1% |
Q4 2017 | $9,903,000 | -10.4% | 7,328,000 | +2.8% | 0.19% | -9.1% |
Q3 2017 | $11,056,000 | -16.7% | 7,131,000 | -8.9% | 0.21% | -17.7% |
Q2 2017 | $13,277,000 | -50.0% | 7,826,000 | -62.0% | 0.25% | -48.8% |
Q1 2017 | $26,533,000 | +13.3% | 20,585,000 | -9.4% | 0.50% | +15.1% |
Q4 2016 | $23,415,000 | +323.4% | 22,721,000 | +291.5% | 0.43% | +438.8% |
Q3 2016 | $5,530,000 | -41.7% | 5,803,000 | -47.2% | 0.08% | -45.2% |
Q4 2015 | $9,492,000 | -43.1% | 11,000,000 | +10.0% | 0.15% | -42.7% |
Q3 2015 | $16,669,000 | – | 10,000,000 | – | 0.26% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 49,064,000 | $47,809,000 | 0.85% |
United Asset Strategies, Inc. | 1,950,000 | $1,915,000 | 0.26% |
HIGHBRIDGE CAPITAL MANAGEMENT LLC | 6,772,000 | $6,637,000 | 0.18% |
PALISADE CAPITAL MANAGEMENT, LP | 1,629,000 | $1,596,000 | 0.04% |
OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) | 1,000,000 | $998,000,000 | 0.01% |
D. E. Shaw & Co., Inc. | 3,380,000 | $3,321,000 | 0.00% |
MACKAY SHIELDS LLC | 110,000 | $110,000 | 0.00% |
UBS Group AG | 3,000 | $3,000 | 0.00% |
Advisory Services Network, LLC | 2,000 | $2,000 | 0.00% |
CITIGROUP INC | 10,000 | $10,000 | 0.00% |